论文信息 - Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study - 字舞流文

Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study

G. Shefer | D. Hagin | R. Eshel | I. Avivi | R. Ben-Ami | D. Shasha | S. Kay | R. Ram | Y. Bar-On | C. Perry | N. Benyamini | Tal Freund | O. Beyar-Katz | A. Apel | R. Gold | C. Glait-Santar | O. Amit | Nino Kikozashvilli | M. Moshiashvili | Chen Karni | C. Glait‐Santar